Evidence map›Paper›PMID 32874838›Full record

ArticleTaiwan journal of ophthalmology

Alteration of expression pattern of transient receptor potential vanilloid 2 and transient receptor potential vanilloid 3 in ocular surface neoplasm.

Ai Izutani-Kitano, Yuka Okada, Kana Ichikawa, Peter Sol Reinach, Shizuya Saika

Open access · diamondAbstract read
In one paragraph

Article in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ai Izutani-KitanoDepartment of Ophthalmology, Kihoku Hospital, Wakayama Medical University, Wakayama, Japan.
Yuka OkadaDepartment of Ophthalmology, School of Medicine, Wakayama Medical University, Wakayama, Japan.
Kana IchikawaDepartment of Ophthalmology, School of Medicine, Wakayama Medical University, Wakayama, Japan.
Peter Sol ReinachSchool of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.
Shizuya SaikaDepartment of Ophthalmology, School of Medicine, Wakayama Medical University, Wakayama, Japan.
Wakayama Medical University · JPKihoku hospital · JPWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe determined if the immunohistochemical expression pattern of transient receptor potential vanilloid (TRPV) family members and TRP ankyrin 1 (TRPA1) differs among a healthy conjunctival epithelium and diseased epithelia. MATERIALS AND

methodsSubjects include a normal conjunctival epithelium, pterygium epithelium, epithelial dysplasia or carcinoma

resultsTRPV1, TRPV4 or TRPA1 was detected in both the cytoplasm and nuclei, or in either the nuclei or cytoplasm, of these different epithelial layers, respectively. There was no difference in the expression pattern of these three TRP isoforms. On the other hand, the expression patterns of TRPV2 and TRPV3 differed dramatically among these different subjects. TRPV2 was observed in the basal layer epithelium of a normal conjunctiva and pterygium. Its pattern was scattered in this region, although TRPV2 was absent throughout most of the dysplastic epithelium. TRPV2 was detected only in some of the suprabasal epithelial cells of a carcinoma

conclusionThese results suggest that TRPV2 and TRPV3 expression pattern analysis might be potential diagnostic markers of ocular surface epithelial disorders.

Indexed as

Carcinoma in situconjunctivadysplasiaepitheliumhumanimmunohistochemistrytransient receptor potential

Identifiers

PMID32874838
PMCPMC7442101
OpenAlexW3028049601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.